Objectives The seroprevalence of antibodies against Cytomegalovirus (CMV) is an established poor prognostic factor for patients receiving an allogeneic stem cell transplantation. However. the impact of CMV serology on outcome after autologous stem cell transplantation remains unknown. Methods Here. https://www.miamistares.shop/product-category/batteries-and-battery-products/